Adherium Limited (ASX:ADR)


right-arrow Created with Sketch. 0 (0%)
MCAP $28.64M
Last trade 16.10pm 18/01/2022 20mins delayed

Latest Announcements

15.28pm 18/01/2022ADRAdherium Limited
13/01/2022ADRAdherium Limited
20/12/2021ADRAdherium Limited
20/12/2021ADRAdherium Limited
02/12/2021ADRAdherium Limited
02/12/2021ADRAdherium Limited
02/12/2021ADRAdherium Limited
02/12/2021ADRAdherium Limited

Company Overview

Adherium Limited is principally engaged in the development, manufacture and supply of its Smartinhaler digital health technologies, which address sub-optimal medication use and improve health outcomes in chronic disease. It offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.

ADR in the news

AstraZeneca awards Adherium (ADR) a supply contract for its US studyADR will…
Respiratory eHealth company Adherium (ADR) has appointed Rick Legleiter as CEO, effective…
Digital health service provider Adherium (ADR) has received commitments from investors to…
Electronic healthcare specialist Adherium (ADR) has called a two-day trading halt today…

Search Previous Announcements